Balancing efficacy and safety of doxorubicin-loaded albumin nanoparticles utilizing pH-sensitive doxorubicin-fatty acid prodrugs-Reference-Cited by-同舟云学术

Balancing efficacy and safety of doxorubicin-loaded albumin nanoparticles utilizing pH-sensitive doxorubicin-fatty acid prodrugs

Published:2024-02-29 Issue:6 Volume:17 Page:5491-5500
ISSN:1998-0124
Container-title:Nano Research
language:en
Short-container-title:Nano Res.

Author:

Yu Yuanhao,Zuo Shiyi,Song Jiaxuan,Li Lingxiao,Liu Tian,Guo Jiayu,Li Yaqiao,Wang Danping,Lu Qi,Wang Helin,Zhou Dun,He Zhonggui,Liu Xiaohong,Sun Bingjun,Sun Jin

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12274-024-6533-5.pdf

Reference34 articles.

1. Li, H.; Wei, W. Y.; Xu, H. X. Drug discovery is an eternal challenge for the biomedical sciences. Acta Mater. Med. 2022, 1, 1–3.

2. Zhao, N.; Woodle, M. C.; Mixson, A. J. Advances in delivery systems for doxorubicin. J. Nanomed. Nanotechnol. 2018, 9, 519.

3. Visscher, H.; Ross, C. J. D.; Rassekh, S. R.; Barhdadi, A.; Dubé, M. P.; Al-Saloos, H.; Sandor, G. S.; Caron, H. N.; van Dalen, E. C.; Kremer, L. C. et al. Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J. Clin. Oncol. 2012, 30, 1422–1428.

4. Wojnowski, L.; Kulle, B.; Schirmer, M.; Schlüter, G.; Schmidt, A.; Rosenberger, A.; Vonhof, S.; Bickeböller, H.; Toliat, M. R.; Suk, E. K. et al. NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Circulation 2005, 112, 3754–3762.

5. Armstrong, J.; Dass, C. R. Doxorubicin action on mitochondria: Relevance to osteosarcoma therapy. Curr. Drug Targets 2018, 19, 432–438.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erratum to: Balancing efficacy and safety of doxorubicin-loaded albumin nanoparticles utilizing pH-sensitive doxorubicin-fatty acid prodrugs;Nano Research;2024-03-20